Literature DB >> 12014725

Effect of probiotic strains on interleukin 8 production by HT29/19A cells.

K M Lammers1, U Helwig, E Swennen, F Rizzello, A Venturi, E Caramelli, M A Kamm, P Brigidi, P Gionchetti, M Campieri.   

Abstract

OBJECTIVES: Promising results from clinical studies on the effect of probiotics as maintenance therapy in inflammatory bowel disease and in the prevention of onset of pouchitis ask for studies to unravel the still poorly understood mechanism of action of probiotics.
METHODS: To evaluate whether the probiotic bacteria that were used in the clinical studies (VSL#3, Escherichia coli Nissle 1917, and Lactobacillus GG) are able to induce chemokine production in epithelial cells, HT29/19A monolayers were incubated with cell debris and cell extract fractions of single strains of the probiotic bacteria in doses ranging from 10(3) to 10(9) colony-forming units/ml for 32 h. Supernatants were measured for interleukin 8 by ELISA.
RESULTS: Lactobacilli and bifidobacteria strains from VSL#3 and Lactobacillus GG did not induce interleukin 8, whereas both cell debris and cell extracts from E. coli Nissle 1917 induced interleukin 8 production in a dose-dependent way. Cell extracts from streptococcal strains induced interleukin 8 when applied at high concentrations.
CONCLUSIONS: Probiotic Gram-positive bacteria did not induce interleukin 8, whereas the nonpathogenic, Gram-negative E. coli Nissle 1917 strain induced interleukin 8 in a dose-dependent way in this culture model. These results suggest that probiotic Gram-positive bacteria and E. coli Nissle 1917 may exert their beneficial effects on the host by a different mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014725     DOI: 10.1111/j.1572-0241.2002.05693.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

1.  Adhesion and immunomodulatory effects of Bifidobacterium lactis HN019 on intestinal epithelial cells INT-407.

Authors:  Chang Liu; Zhuo-Yang Zhang; Ke Dong; Xiao-Kui Guo
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Probiotics and barrier function in colitis.

Authors:  P Gionchetti; K M Lammers; F Rizzello; M Campieri
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  Probiotics manipulate host cytokine response and induce antimicrobial peptides.

Authors:  I Trebichavský; I Splíchal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 4.  Probiotics and inflammatory bowel diseases.

Authors:  A-P Bai; Q Ouyang
Journal:  Postgrad Med J       Date:  2006-06       Impact factor: 2.401

5.  Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.

Authors:  Ulf Helwig; Karen M Lammers; Fernando Rizzello; Patricia Brigidi; Verena Rohleder; Elisabetta Caramelli; Paolo Gionchetti; Juergen Schrezenmeir; Ulrich R Foelsch; Stefan Schreiber; Massimo Campieri
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

6.  Role of probiotics in correcting abnormalities of colonic flora induced by stress.

Authors:  Helene Eutamene; Lionel Bueno
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

7.  Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice.

Authors:  A Kokesová; L Frolová; M Kverka; D Sokol; P Rossmann; J Bártová; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 8.  NSAID enteropathy: could probiotics prevent it?

Authors:  Massimo Montalto; Antonella Gallo; Antonio Gasbarrini; Raffaele Landolfi
Journal:  J Gastroenterol       Date:  2012-08-09       Impact factor: 7.527

Review 9.  Probiotics: properties, examples, and specific applications.

Authors:  Judith Behnsen; Elisa Deriu; Martina Sassone-Corsi; Manuela Raffatellu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

10.  Infant intestinal Enterococcus faecalis down-regulates inflammatory responses in human intestinal cell lines.

Authors:  Shugui Wang; Lydia Hui Mei Ng; Wai Ling Chow; Yuan Kun Lee
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.